From the Agenda

The last hurdle? : Management and strategies for preparing a Biosimilar dossier

2016-11-22 11:45:00

Dr.Christopher Mann

Scientific and Regulatory Affairs Manager

  • PhD in Biomedicine.
  • Academic research in gene therapy, regeneration and muscular dystrophy, diabetes.
  • He has published numerous original research papers and review articles in peer reviewed journals.
  • Expert in medical and scientific writing for Biosimilars, Innovative, Biological, Biotechnological, and Advanced Therapy Medicinal Products, including gene and somatic cell therapies.
  • Currently working in medical writing for Paediatric Investigation Plans, Scientific Advice/Pre-IND meetings and Centralized Procedures.
  • Experience in Biosimilars CP writing Clinical and Pre-Clinical.
  • World wide experience in Biosimilars Gap Analysis and writing.